KRRO
Frequency Therapeutics Inc
NASDAQ: KRRO · HEALTHCARE · BIOTECHNOLOGY
$13.49
+6.98% today
Updated 2026-04-30
Market cap
$196.07M
P/E ratio
—
P/S ratio
30.68x
EPS (TTM)
$-12.48
Dividend yield
—
52W range
$5 – $56
Volume
0.2M
Frequency Therapeutics Inc (KRRO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,229.00%
ROE
-110.70%
ROA
-32.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-20.24M | — | — | — |
| 2018 | — | $-19.17M | — | — | — |
| 2019 | $28.95M | $-18.75M | 41.92% | -71.42% | -64.76% |
| 2020 | $36.98M | $-26.51M | 95.73% | -74.49% | -71.68% |
| 2021 | $14.07M | $-84.69M | 72.70% | -597.32% | -601.98% |
| 2022 | $0.00 | $-58.03M | — | — | — |
| 2023 | $0.00 | $-81.17M | — | — | — |
| 2024 | $2.27M | $-83.58M | 100.00% | -4,047.12% | -3,680.36% |
| 2025 | $6.39M | $-117.26M | 33.04% | -1,366.43% | -1,834.48% |